The cancer fighting group called Tempus is trying to give more help to the doctors at the University of Chicago. Eric Lefkofsky, the founder of Tempus wants breast cancer patients to have better treatments available. For this purpose Tempus and the University of Chicago have achieved a partnership.One of the most common types of cancer is breast cancer yet there is not much data accessible on the people who have fought the disease. Doctors are forced to make decisions regarding treatment without information that could aid in the process.
Genomic sequencing and machine learning are used by Tempus to help doctors make more personal decisions in the treatment of their patients. This process was started in 2015 and just recently came to light.Tempus has been setting up numerous partnerships. They work with the University of Michigan, the Robert H. Lurie Comprehensive Cancer Center, Penn Medicine, the Mayo Clinic and Rush University Medical Center in the pursuit of data that can be used in the fight against cancer.
Eric Lefkofsky is one of the founders as well as the CEO of Tempus. He was also a partner in the founding of Lightbank. This is a venture fund specializing in disruptive technologies. Mr. Lefkofsky is well known as the Chairman and co-founder of Groupon, a highly successful e-commerce website.Mr. Lefkofsky started the Lefkofsky Family Foundation in 2006 along with his wife Liz. This private charitable foundation works to advance initiatives that positively affect the lives of the people in the communities they serve. Mr. Lefkofsky is a Trustee at many worthwhile organizations. These include World Business Chicago, The Museum of Science and Industry, The Art Institute of Chicago and the Lurie Children’s Hospital of Chicago.Mr. Lefkofsky is on the board for the Chicago’s Steppenwolf Theatre Company as well as supporting the University of Chicago. In addition he has written Accelerated Disruption. Mr. Lefkofsky attended the University of Michigan where he graduated then earned his Juris Doctor in Law school.